Korea Exchange Resolves to Delist Kolon TissueGene Amid 'Invossa Scandal'
[Asia Economy Reporter Eunmo Koo] The Korea Exchange held a KOSDAQ Market Committee meeting and deliberated and resolved to delist Kolon TissueGene, according to a disclosure on the 4th. Kolon TissueGene can file an objection within 7 business days from the date of receiving the delisting notice. If no objection is filed, the Exchange will proceed with the delisting process.
Hot Picks Today
No Bacteria Detected in Arisu After 24 Hours of Repeated Drinking from a Tumbler
- "I Feel Uncomfortable Being Filmed"... Cheerleaders Distressed by Commercial Fan Cam Practices
- Staring at Stock Charts Causes 'Hwabyeong'... "What Have I Even Been Doing?" FOMO Spreads Amid Soaring KOSPI
- High-Net-Worth Investors Increase Stock Holdings: "Samsung and SK hynix Are Basic, Now Searching for the Next Opportunity" [Investment Strategies of the Wealthy] ⑧
- Police Officer Cycling on Day Off Rescues Woman Attempting to Jump from Hangju Bridge
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
